A pop-up pharmacy clinic offering screening services after breakfast[/caption]
Case scenario
Mr Kea, 30, is a regular patient at your pharmacy. He has been stable on olanzapine for 1.5 years with no recent psychotic episodes.
Today, Mr Kea seems flat. He shows you a photo on his phone of a box of aripiprazole that his housemate, who also has schizophrenia, sent him. His housemate seems to be doing well. ‘He’s not putting on weight like me,’ Mr Kea says. ‘Can I just swap to what he’s on?’
You check Mr Kea’s dispensing history and note that he has not collected his olanzapine this month.
Learning outcomesAfter reading this article, pharmacists should be able to: Describe the prevalence and key features of schizophrenia Discuss risk factors for developing schizophrenia and diagnostic criteria Describe factors associated with morbidity and mortality among people living with schizophrenia Discuss key considerations associated with the use of antipsychotics. Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.1, 2.2, 3.1, 3.2, 3.3, 3.5 Accreditation number: PSAAP2606SD Accreditation expiry: 31/05/2028 Accreditation points: 1.5 Group 2 credits |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
